$CLVT

CLARIVATE PLC (CLVT): Other Events

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities LONDON, September 17, 2026: Clarivate Plc (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary,

Original reporting
Published Sep 17, 2026, 12:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 12:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CLVT
Neutral
high confidence
Mentioned
$CLVT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CLVTNeutralHigh
01

Why it matters

The offer provides a clear exit option for note holders and may improve Clarivate's balance sheet, influencing equity valuation.

02

Market read

First report of a debt tender offer; traders can act on the terms and deadline.

03

What to watch

Potential impact of interest‑rate movements on the attractiveness of the fixed‑rate notes.

Relevance 7/10Novelty 8/10Timing: offer expires Sep 23, 2026

Background

Clarivate Science Holdings Corp., a wholly‑owned subsidiary of Clarivate PLC, is conducting the tender offer for its senior secured notes.

Company-level read

Ticker impact

$CLVTNeutralHigh confidence
Context

Clarivate announced a cash tender offer to repurchase up to $75M of its 3.875% senior secured notes due 2028.

Expected impact

Potential modest upside for CLVT equity if the tender is viewed positively; bond prices may tighten.

Evidence & confidence

First disclosure of the offer, clear terms, and a defined cap provide actionable information for traders.

Market effects

May influence other data‑analytics and information‑services firms as investors compare debt strategies.

Primarily U.S. market, with limited broader regional effect.

Limited to investors tracking corporate debt tender offers.

Counterpoint

If the tender is seen as a sign of cash strain, the stock could face downside pressure.

Key entities

  • Clarivate PLC

    Issuer of the senior secured notes and parent of the subsidiary conducting the tender.

  • Citigroup Global Markets Inc.

    Acting as dealer manager for the tender offer.

Related articles

$CLVTMed

Clarivate Plc: Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

Clarivate Plc (NYSE: CLVT) announced a cash tender offer to purchase up to $75M of its 3.875% Senior Secured Notes due 2028. The offer, managed by Citigroup, expires on September 23, 2026, with a settlement date of September 25, 2026. The total consideration is based on a fixed spread and reference yield, with accrued interest also payable.

$CLVTMed

Clarivate Plc Q2 2026 Earnings Call Summary

Clarivate Plc (Q2 2026) discussed its Value Creation Plan to shift from transactional to recurring subscription revenue. It plans to divest the Life Sciences & Healthcare segment by year-end 2026, targeting about 92% recurring revenue pro forma. Management cited a $269m non-cash impairment, $70m one-time costs, and expects low-end FCF due to transaction and restructuring costs.

$CLVTMed

Clarivate Reports Second Quarter 2026 Results

Clarivate Plc (NYSE: CLVT) reported Q2 2026 results for the quarter ended June 30. Total revenue fell to $587.3 million from $621.4 million a year earlier, while organic revenues declined 1.5%. Net loss widened to $268.6 million due to a $221.7 million goodwill impairment; adjusted net income was $123.1 million. The company reaffirmed its 2026 outlook and cited a Life Sciences & Healthcare divestiture.

$CLVTMedAI 8/10

CLARIVATE PLC (CLVT): Results of Operations and Financial Condition

CLARIVATE PLC (CLVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 Clarivate Reports Second Quarter 2026 Results — Delivers continued progress on strategic and financial priorities through Value Creation Plan — — Sharpens focus and enhances financial profile with previously announced Life Sciences & Healthcare segment divestiture — — Reaffirms